68Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review

68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour

(2017) Christian Uprimny et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer

(2017) Philip Cornford et al.   EUROPEAN UROLOGY

Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer

(2016) Pim J. van Leeuwen et al.   BJU INTERNATIONAL

68Ga-PSMA-11 Dynamic PET/CT Imaging in Primary Prostate Cancer

(2016) Christos Sachpekidis et al.   CLINICAL NUCLEAR MEDICINE

Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CT

(2016) Johannes Schwenck et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Initial Experience of 68Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy

(2016) Lars Budäus et al.   EUROPEAN UROLOGY

68Ga-PSMA Positron Emission Tomography/Computed Tomography Provides Accurate Staging of Lymph Node Regions Prior to Lymph Node Dissection in Patients with Prostate Cancer

(2016) Annika Herlemann et al.   EUROPEAN UROLOGY

Sensitivity, Specificity, and Predictors of Positive 68 Ga–Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis

(2016) Marlon Perera et al.   EUROPEAN UROLOGY

Correlation of Intraprostatic Tumor Extent with 68Ga-PSMA Distribution in Patients with Prostate Cancer

(2016) K. Rahbar et al.   JOURNAL OF NUCLEAR MEDICINE

Diagnostic Efficacy of 68Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer

(2016) Tobias Maurer et al.   JOURNAL OF UROLOGY

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

68Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients

(2015) Florian Sterzing et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging

(2015) Levent Kabasakal et al.   NUCLEAR MEDICINE COMMUNICATIONS

Pelvic lymph node dissection for nodal oligometastatic prostate cancer detected by68Ga-PSMA-positron emission tomography/computerized tomography

(2015) S. Hijazi et al.   PROSTATE

Prostate-specific membrane antigen-based imaging in prostate cancer: Impact on clinical decision making process

(2015) Mehmet Onur Demirkol et al.   PROSTATE

The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

(2014) Ali Afshar-Oromieh et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

The Clinical Value of Diffusion-Weighted Imaging in Combination With T2-Weighted Imaging in Diagnosing Prostate Carcinoma: A Systematic Review and Meta-Analysis

(2012) Lian-Ming Wu et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging

(2012) Matthias Eder et al.   BIOCONJUGATE CHEMISTRY

PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions

(2012) A. Afshar-Oromieh et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis

(2008) A.M. Hövels et al.   CLINICAL RADIOLOGY